Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 51: 25-26, 2005. First published November 11, 2004; 10.1373/clinchem.2004.042523
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.042523v1
51/1/25    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ismail, A. A.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ismail, A. A.A.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Clinical Immunology
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2005;51:25-26.)
© 2005 American Association for Clinical Chemistry, Inc.


Opinion

A Radical Approach Is Needed to Eliminate Interference from Endogenous Antibodies in Immunoassays

Adel A.A. Ismail

1 Consultant in Clinical Biochemistry and Chemical Endocrinology (Retired), "Tanglewood", Chevet Lane, Sandal, Wakefield, West Yorkshire, UK, E-mail adelaaismail@aol.com

The first 20% of the full text of this article appears below.

Interference in immunoassays by circulating endogenous antibodies is as old as the technique itself. Its mechanisms have remained poorly studied, however, and its detrimental effects are underestimated despite numerous reports highlighting its serious consequences (1)(2)(3)(4)(5)(6)(7)(8)(9). One reason for this situation is that immunoassays are moving targets. Assay protocols and reagents, even from the same provider and for the same analyte, may change every few years. Even when research on a method is published, it may be perceived as method-dependent and obsolete by the time of publication as the technique may have been altered in the interim.

Defining the precise mechanisms of interference by endogenous antibodies has been challenging because of variation in the phenomena produced by the antibodies. Endogenous antibodies may increase readings in some assays but decrease the results in others (4)(5). Interfering antibodies may be identified by nonlinearity in some assays but show perfect linearity on serial dilution in others (5). Interference from some antibodies may be blocked by commercially available "blocking reagents", but interferences from other antibodies are not (5). Repeat analyses by other methods may identify samples with interfering antibodies, with the comparison assay yielding gross disparity, but in other cases good agreement may be seen between two methods (4)(5).

The purpose of this report is to attempt to highlight some of the potential underlying mechanisms of interference from endogenous antibodies and to show that these mechanisms suggest that this interference is and will remain an insidious, . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Ann Clin BiochemHome page
M. Fahie-Wilson and D. Halsall
Polyethylene glycol precipitation: proceed with care
Ann Clin Biochem, May 1, 2008; 45(3): 233 - 235.
[Full Text] [PDF]


Home page
CVIHome page
M. Berth and E. Bosmans
Prevention of Assay Interference in Infectious-Disease Serology Tests Done on the Liaison Platform
Clin. Vaccine Immunol., May 1, 2008; 15(5): 891 - 892.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Mori, S. R. Martinez, S. J. O'Day, D. L. Morton, N. Umetani, M. Kitago, A. Tanemura, S. L. Nguyen, A. N. Tran, H.-J. Wang, et al.
Estrogen Receptor-{alpha} Methylation Predicts Melanoma Progression.
Cancer Res., July 1, 2006; 66(13): 6692 - 6698.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
U.-H. Stenman
Improving Immunoassay Performance by Antibody Engineering
Clin. Chem., May 1, 2005; 51(5): 801 - 802.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Bjerner, O. P. Bormer, and K. Nustad
The War on Heterophilic Antibody Interference
Clin. Chem., January 1, 2005; 51(1): 9 - 11.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.